BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28544973)

  • 21. Dendritic Cell Sensing of Hydrophobic Di- and Triacylated Lipopeptides Self-Assembled within Synthetic Virus-like Particles.
    Sharma R; Ghasparian A; Robinson JA; McCullough KC
    J Immunol; 2017 Jul; 199(2):734-749. PubMed ID: 28630093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
    Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
    J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-adjuvanted L-arginine-modified dextran-based nanogels for sustained local antigenic protein delivery to antigen-presenting cells and enhanced cellular and humoral immune responses.
    Chung JT; Rafiei M; Chau Y
    Biomater Sci; 2024 Mar; 12(7):1771-1787. PubMed ID: 38385306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple nanoliposomes encapsulating
    Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
    Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
    J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The second and third amino acids of Pam2 lipopeptides are key for the proliferation of cytotoxic T cells.
    Takeda Y; Azuma M; Hatsugai R; Fujimoto Y; Hashimoto M; Fukase K; Matsumoto M; Seya T
    Innate Immun; 2018 Jul; 24(5):323-331. PubMed ID: 29848176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
    Cottalorda A; Mercier BC; Mbitikon-Kobo FM; Arpin C; Teoh DY; McMichael A; Marvel J; Bonnefoy-Bérard N
    Eur J Immunol; 2009 Oct; 39(10):2673-81. PubMed ID: 19634192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a dendritic cell-targeting lipopeptide as an immunoadjuvant that inhibits tumor growth without inducing local inflammation.
    Akazawa T; Ohashi T; Nakajima H; Nishizawa Y; Kodama K; Sugiura K; Inaba T; Inoue N
    Int J Cancer; 2014 Dec; 135(12):2847-56. PubMed ID: 24789268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
    Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
    PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
    Borsutzky S; Kretschmer K; Becker PD; Mühlradt PF; Kirschning CJ; Weiss S; Guzmán CA
    J Immunol; 2005 May; 174(10):6308-13. PubMed ID: 15879130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
    Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
    Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
    J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
    Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
    Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response.
    Kaur R; Bramwell VW; Kirby DJ; Perrie Y
    J Control Release; 2012 Dec; 164(3):331-7. PubMed ID: 22800572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
    Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F
    Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maturation of dendritic cells in vitro and immunological enhancement of mice in vivo by pachyman- and/or OVA-encapsulated poly(d,l-lactic acid) nanospheres.
    Zheng S; Qin T; Lu Y; Huang Y; Luo L; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2018; 13():569-583. PubMed ID: 29416336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
    Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
    Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired cross-presentation of CD8α+ CD11c+ dendritic cells by Japanese encephalitis virus in a TLR2/MyD88 signal pathway-dependent manner.
    Aleyas AG; Han YW; Patil AM; Kim SB; Kim K; Eo SK
    Eur J Immunol; 2012 Oct; 42(10):2655-66. PubMed ID: 22706912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.